While ITGβ7 is not specific to myeloma, its constitutive activation exposes an epitope that can be recognized by a conformation-dependent CAR T cell that has demonstrated potent and selective killing of myeloma cells in vitro and in vivo.199. This evidence concerns the gene ITGB7 and plasma cell myeloma.